![Ramesh Hariharan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ramesh Hariharan
Corporate Officer/Principal bei NATERA, INC.
Aktive Positionen von Ramesh Hariharan
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
NATERA, INC. | Corporate Officer/Principal | - | - |
Vertrieb & Marketing | - | - |
Karriereverlauf von Ramesh Hariharan
Ehemalige bekannte Positionen von Ramesh Hariharan
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Biotheranostics, Inc.
![]() Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Biotheranostics, Inc. develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. It has commercialized two proprietary, highly differentiated products focused on early stage breast cancer and all metastatic cancers, Breast Cancer Index (BCI) and CancerTYPE ID (CTID). The company was founded by Thomas M. Baer in 2008 and is headquartered in San Diego, CA. | Vertrieb & Marketing | 23.07.2014 | 01.04.2016 |
Ausbildung von Ramesh Hariharan
Indian Institute of Technology Bombay | Undergraduate Degree |
Princeton University | Doctorate Degree |
Mit Solan School of Management | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 5 |
Indien | 2 |
Operativ
Sales & Marketing | 2 |
Undergraduate Degree | 1 |
Doctorate Degree | 1 |
Sektoral
Consumer Services | 4 |
Health Services | 2 |
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
NATERA, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Biotheranostics, Inc.
![]() Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Biotheranostics, Inc. develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. It has commercialized two proprietary, highly differentiated products focused on early stage breast cancer and all metastatic cancers, Breast Cancer Index (BCI) and CancerTYPE ID (CTID). The company was founded by Thomas M. Baer in 2008 and is headquartered in San Diego, CA. | Health Services |
- Börse
- Insiders
- Ramesh Hariharan
- Erfahrung